rs532223684

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_021098.3(CACNA1H):​c.1517G>A​(p.Arg506Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000151 in 1,544,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R506G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 1.89

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.022917151).
BP6
Variant 16-1201967-G-A is Benign according to our data. Variant chr16-1201967-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 529607.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000243 (37/152260) while in subpopulation AMR AF = 0.00131 (20/15310). AF 95% confidence interval is 0.000865. There are 0 homozygotes in GnomAd4. There are 21 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 37 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1478G>A p.Arg493Gln missense_variant Exon 9 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1478G>A p.Arg493Gln missense_variant Exon 9 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1517G>A p.Arg506Gln missense_variant Exon 9 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000711442.1 linkn.*964G>A non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1517G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*964G>A 3_prime_UTR_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000640028.1 linkn.1385+132G>A intron_variant Intron 9 of 34 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.000243
AC:
37
AN:
152142
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000206
AC:
29
AN:
140622
AF XY:
0.000211
show subpopulations
Gnomad AFR exome
AF:
0.000153
Gnomad AMR exome
AF:
0.000246
Gnomad ASJ exome
AF:
0.000734
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000214
Gnomad OTH exome
AF:
0.000480
GnomAD4 exome
AF:
0.000141
AC:
196
AN:
1391996
Hom.:
0
Cov.:
36
AF XY:
0.000136
AC XY:
93
AN XY:
685902
show subpopulations
African (AFR)
AF:
0.0000635
AC:
2
AN:
31490
American (AMR)
AF:
0.000422
AC:
15
AN:
35582
Ashkenazi Jewish (ASJ)
AF:
0.000717
AC:
18
AN:
25088
East Asian (EAS)
AF:
0.0000281
AC:
1
AN:
35616
South Asian (SAS)
AF:
0.000202
AC:
16
AN:
79112
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5584
European-Non Finnish (NFE)
AF:
0.000115
AC:
124
AN:
1076306
Other (OTH)
AF:
0.000346
AC:
20
AN:
57798
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000243
AC:
37
AN:
152260
Hom.:
0
Cov.:
34
AF XY:
0.000282
AC XY:
21
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41548
American (AMR)
AF:
0.00131
AC:
20
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
67994
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000203
Hom.:
0
Bravo
AF:
0.000264
ExAC
AF:
0.000110
AC:
6
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Dec 21, 2017
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

See cases Uncertain:1
May 16, 2019
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG classification criteria: PM2 -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
15
DANN
Benign
0.72
DEOGEN2
Benign
0.15
T;.;.;.
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.73
T;T;T;.
M_CAP
Pathogenic
0.50
D
MetaRNN
Benign
0.023
T;T;T;T
MetaSVM
Uncertain
0.019
D
MutationAssessor
Benign
1.7
L;.;L;L
PhyloP100
1.9
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.3
N;.;N;N
REVEL
Benign
0.23
Sift
Benign
0.59
T;.;T;T
Sift4G
Benign
0.22
T;.;T;T
Polyphen
0.0070
B;.;B;B
Vest4
0.096
MutPred
0.38
Loss of MoRF binding (P = 0.0846);.;Loss of MoRF binding (P = 0.0846);Loss of MoRF binding (P = 0.0846);
MVP
0.76
ClinPred
0.012
T
GERP RS
2.9
Varity_R
0.085
gMVP
0.32
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs532223684; hg19: chr16-1251967; COSMIC: COSV104661970; COSMIC: COSV104661970; API